Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells
Gaurav Pathria(GenVec), Stephan N. Wagner(Medical University of Vienna)
Cited by 23
Related Papers
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
|Nature Communications|2019|374
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
|Nature Communications|2017|141
MTSS1 is a metastasis driver in a subset of human melanomas
|Nature Communications|2014|63
NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
|PLoS ONE|2013|48
Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLC
|npj Precision Oncology|2024|8